Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
GSK3145095 is a small molecule that inhibits RIPK1, resulting in decreased downstream signaling, and potentially leading to reduced recruitment of immunosuppressive cells in the tumor microenvironment and increased tumor cell death (PMID: 31223438).
|CAS Registry Number||1622849-43-7|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|GSK3145095 + Pembrolizumab||GSK3145095 Pembrolizumab||0||1|